U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Links from Gene

Myofibrillar myopathy 3(MFM3)

MedGen UID:
811509
Concept ID:
C3714934
Disease or Syndrome
Synonyms: Autosomal dominant spheroid body myopathy; Limb-girdle muscular dystrophy, type 1A; MFM3; Muscular dystrophy, proximal, type 1A; Spheroid body myopathy
 
Gene (location): MYOT (5q31.2)
 
Monarch Initiative: MONDO:0012215
OMIM®: 609200

Definition

Myofibrillar myopathy refers to a genetically heterogeneous group of muscular disorders characterized by a pathologic morphologic pattern of myofibrillar degradation and abnormal accumulation of proteins involved with the sarcomeric Z disc (summary by Foroud et al., 2005). For a general phenotypic description and a discussion of genetic heterogeneity of myofibrillar myopathy, see MFM1 (601419). [from OMIM]

Additional description

From MedlinePlus Genetics
Other signs and symptoms of myofibrillar myopathy can include a weakened heart muscle (cardiomyopathy), muscle pain (myalgia), loss of sensation and weakness in the limbs (peripheral neuropathy), and respiratory failure. Individuals with this condition may have skeletal problems including joint stiffness (contractures) and abnormal side-to-side curvature of the spine (scoliosis). Rarely, people with this condition develop clouding of the lens of the eyes (cataracts).

The signs and symptoms of myofibrillar myopathy vary widely among affected individuals, typically depending on the condition's genetic cause. Most people with this disorder begin to develop muscle weakness (myopathy) in mid-adulthood. However, features of this condition can appear anytime between infancy and late adulthood. Muscle weakness most often begins in the hands and feet (distal muscles), but some people first experience weakness in the muscles near the center of the body (proximal muscles). Other affected individuals develop muscle weakness throughout their body. Facial muscle weakness can cause swallowing and speech difficulties. Muscle weakness worsens over time.

Myofibrillar myopathy is part of a group of disorders called muscular dystrophies that affect muscle function and cause weakness. Myofibrillar myopathy primarily affects skeletal muscles, which are muscles that the body uses for movement. In some cases, the heart (cardiac) muscle is also affected.  https://medlineplus.gov/genetics/condition/myofibrillar-myopathy

Clinical features

From HPO
Myalgia
MedGen UID:
68541
Concept ID:
C0231528
Sign or Symptom
Pain in muscle.
Hyporeflexia of lower limbs
MedGen UID:
371881
Concept ID:
C1834696
Finding
Reduced intensity of muscle tendon reflexes in the lower limbs. Reflexes are elicited by stretching the tendon of a muscle, e.g., by tapping.
Cardiomyopathy
MedGen UID:
209232
Concept ID:
C0878544
Disease or Syndrome
A myocardial disorder in which the heart muscle is structurally and functionally abnormal, in the absence of coronary artery disease, hypertension, valvular disease and congenital heart disease sufficient to cause the observed myocardial abnormality.
Polyneuropathy
MedGen UID:
57502
Concept ID:
C0152025
Disease or Syndrome
A generalized disorder of peripheral nerves.
Areflexia
MedGen UID:
115943
Concept ID:
C0234146
Finding
Absence of neurologic reflexes such as the knee-jerk reaction.
Muscle stiffness
MedGen UID:
113151
Concept ID:
C0221170
Sign or Symptom
A condition in which muscles cannot be moved quickly without accompanying pain or spasm.
Proximal muscle weakness
MedGen UID:
113169
Concept ID:
C0221629
Finding
A lack of strength of the proximal muscles.
Achilles tendon contracture
MedGen UID:
98052
Concept ID:
C0410264
Anatomical Abnormality
A contracture of the Achilles tendon.
Muscle fiber splitting
MedGen UID:
322813
Concept ID:
C1836057
Finding
Fiber splitting or branching is a common finding in human and rat skeletal muscle pathology. Fiber splitting refers to longitudinal halving of the complete fiber, while branching originates from a regenerating end of a necrotic fiber as invaginations of the sarcolemma. In fiber branching, one end of the fiber remains intact as a single entity, while the other end has several branches.
Progressive distal muscle weakness
MedGen UID:
324556
Concept ID:
C1836609
Finding
Progressively reduced strength of the distal musculature.
Centrally nucleated skeletal muscle fibers
MedGen UID:
330782
Concept ID:
C1842170
Finding
An abnormality in which the nuclei of sarcomeres take on an abnormally central localization (or in which this feature is found in an increased proportion of muscle cells).
Increased variability in muscle fiber diameter
MedGen UID:
336019
Concept ID:
C1843700
Finding
An abnormally high degree of muscle fiber size variation. This phenotypic feature can be observed upon muscle biopsy.
Distal amyotrophy
MedGen UID:
338530
Concept ID:
C1848736
Disease or Syndrome
Muscular atrophy affecting muscles in the distal portions of the extremities.
Myofibrillar myopathy
MedGen UID:
395532
Concept ID:
C2678065
Finding
Other signs and symptoms of myofibrillar myopathy can include a weakened heart muscle (cardiomyopathy), muscle pain (myalgia), loss of sensation and weakness in the limbs (peripheral neuropathy), and respiratory failure. Individuals with this condition may have skeletal problems including joint stiffness (contractures) and abnormal side-to-side curvature of the spine (scoliosis). Rarely, people with this condition develop clouding of the lens of the eyes (cataracts).\n\nThe signs and symptoms of myofibrillar myopathy vary widely among affected individuals, typically depending on the condition's genetic cause. Most people with this disorder begin to develop muscle weakness (myopathy) in mid-adulthood. However, features of this condition can appear anytime between infancy and late adulthood. Muscle weakness most often begins in the hands and feet (distal muscles), but some people first experience weakness in the muscles near the center of the body (proximal muscles). Other affected individuals develop muscle weakness throughout their body. Facial muscle weakness can cause swallowing and speech difficulties. Muscle weakness worsens over time.\n\nMyofibrillar myopathy is part of a group of disorders called muscular dystrophies that affect muscle function and cause weakness. Myofibrillar myopathy primarily affects skeletal muscles, which are muscles that the body uses for movement. In some cases, the heart (cardiac) muscle is also affected.
Muscle fiber cytoplasmatic inclusion bodies
MedGen UID:
867767
Concept ID:
C4022157
Finding
The presence of inclusion bodies within the cytoplasm of muscle cells. Inclusion bodies are aggregates (deposits) or stainable material, usually misfolded proteins.
Elevated circulating creatine kinase concentration
MedGen UID:
69128
Concept ID:
C0241005
Finding
An elevation of the level of the enzyme creatine kinase (also known as creatine phosphokinase (CK; EC 2.7.3.2) in the blood. CK levels can be elevated in a number of clinical disorders such as myocardial infarction, rhabdomyolysis, and muscular dystrophy.

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  

Recent clinical studies

Etiology

Felice KJ
Neurol Clin 2020 Aug;38(3):637-659. Epub 2020 Jun 11 doi: 10.1016/j.ncl.2020.03.007. PMID: 32703474
Milone M, Liewluck T
Muscle Nerve 2019 Mar;59(3):283-294. Epub 2018 Nov 28 doi: 10.1002/mus.26332. PMID: 30171629
Weihl CC, Iyadurai S, Baloh RH, Pittman SK, Schmidt RE, Lopate G, Pestronk A, Harms MB
Neuromuscul Disord 2015 Mar;25(3):199-206. Epub 2014 Dec 12 doi: 10.1016/j.nmd.2014.12.002. PMID: 25557463Free PMC Article
Latham GJ, Lopez G
Paediatr Anaesth 2015 Mar;25(3):231-8. Epub 2014 Sep 12 doi: 10.1111/pan.12516. PMID: 25216331
Selcen D
Neuromuscul Disord 2011 Mar;21(3):161-71. Epub 2011 Jan 20 doi: 10.1016/j.nmd.2010.12.007. PMID: 21256014Free PMC Article

Diagnosis

Felice KJ
Neurol Clin 2020 Aug;38(3):637-659. Epub 2020 Jun 11 doi: 10.1016/j.ncl.2020.03.007. PMID: 32703474
Shaibani A
Neurol Clin 2016 Aug;34(3):547-64. doi: 10.1016/j.ncl.2016.04.014. PMID: 27445241
Dimachkie MM, Barohn RJ
Neurol Clin 2014 Aug;32(3):817-42, x. Epub 2014 May 15 doi: 10.1016/j.ncl.2014.04.004. PMID: 25037092Free PMC Article
Claeys KG, Fardeau M
Handb Clin Neurol 2013;113:1337-42. doi: 10.1016/B978-0-444-59565-2.00005-8. PMID: 23622358
Selcen D
Neuromuscul Disord 2011 Mar;21(3):161-71. Epub 2011 Jan 20 doi: 10.1016/j.nmd.2010.12.007. PMID: 21256014Free PMC Article

Therapy

Loarce-Martos J, Lilleker JB, Parker M, McHugh N, Chinoy H
Rheumatology (Oxford) 2021 Jul 1;60(7):3398-3403. doi: 10.1093/rheumatology/keaa801. PMID: 33367878

Prognosis

Zhan L, Lv L, Chen X, Xu X, Ni J
Medicine (Baltimore) 2022 Jan 7;101(1):e28484. doi: 10.1097/MD.0000000000028484. PMID: 35029900Free PMC Article
Scarpini G, Valentino ML, Giannotta M, Ragni L, Torella A, Columbaro M, Nigro V, Pini A
Acta Myol 2021 Dec;40(4):177-183. Epub 2021 Dec 31 doi: 10.36185/2532-1900-061. PMID: 35047758Free PMC Article
Nicolau S, Milone M, Tracy JA, Mills JR, Triplett JD, Liewluck T
Muscle Nerve 2021 Dec;64(6):734-739. Epub 2021 Oct 15 doi: 10.1002/mus.27435. PMID: 34617293
Alhammad RM, Naddaf E
Neuromuscul Disord 2020 Feb;30(2):128-136. Epub 2019 Dec 12 doi: 10.1016/j.nmd.2019.12.001. PMID: 32005492
Andersen AG, Fornander F, Schrøder HD, Krag T, Straub V, Duno M, Vissing J
Neuromuscul Disord 2018 Sep;28(9):798-801. Epub 2018 Jul 5 doi: 10.1016/j.nmd.2018.06.019. PMID: 30061062

Clinical prediction guides

Scarpini G, Valentino ML, Giannotta M, Ragni L, Torella A, Columbaro M, Nigro V, Pini A
Acta Myol 2021 Dec;40(4):177-183. Epub 2021 Dec 31 doi: 10.36185/2532-1900-061. PMID: 35047758Free PMC Article
Ruparelia AA, McKaige EA, Williams C, Schulze KE, Fuchs M, Oorschot V, Lacene E, Meregalli M, Lee C, Serrano RJ, Baxter EC, Monro K, Torrente Y, Ramm G, Stojkovic T, Lavoie JN, Bryson-Richardson RJ
Autophagy 2021 Sep;17(9):2494-2510. Epub 2020 Oct 19 doi: 10.1080/15548627.2020.1833500. PMID: 33030392Free PMC Article
Andersen AG, Fornander F, Schrøder HD, Krag T, Straub V, Duno M, Vissing J
Neuromuscul Disord 2018 Sep;28(9):798-801. Epub 2018 Jul 5 doi: 10.1016/j.nmd.2018.06.019. PMID: 30061062
Yogev Y, Perez Y, Noyman I, Madegem AA, Flusser H, Shorer Z, Cohen E, Kachko L, Michaelovsky A, Birk R, Koifman A, Drabkin M, Wormser O, Halperin D, Kadir R, Birk OS
Eur J Hum Genet 2017 Aug;25(8):966-972. Epub 2017 May 10 doi: 10.1038/ejhg.2017.85. PMID: 28488683Free PMC Article
Melberg A, Oldfors A, Blomström-Lundqvist C, Stålberg E, Carlsson B, Larrson E, Lidell C, Eeg-Olofsson KE, Wikström G, Henriksson G, Dahl N
Ann Neurol 1999 Nov;46(5):684-92. doi: 10.1002/1531-8249(199911)46:5<684::aid-ana2>3.0.co;2-#. PMID: 10970245

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...